Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05592990
Other study ID # CNGI226A12201
Secondary ID
Status Recruiting
Phase Phase 2
First received
Last updated
Start date June 14, 2023
Est. completion date July 1, 2025

Study information

Verified date June 2024
Source Novartis
Contact Novartis Pharmaceuticals
Phone 1-888-669-6682
Email novartis.email@novartis.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to measure local and systemic safety and tolerability as well as improvement of Achilles tendon mechanical properties after a single peritendon injection of NGI226 MP in comparison to placebo MP in patients with mid-portion Achilles tendinopathy.


Recruitment information / eligibility

Status Recruiting
Enrollment 46
Est. completion date July 1, 2025
Est. primary completion date July 1, 2025
Accepts healthy volunteers No
Gender All
Age group 30 Years to 70 Years
Eligibility Inclusion Criteria: - Written informed consent must be obtained prior to all study specific screening procedures, as close to the start of the screening period as possible. - Presence of clinically (local Achilles tendon pain on tendon-loading activities, pain on palpation at the level 2-6 cm proximal to the calcaneal insertion) and ultrasound (local tendon thickening with hypoechogenicities and irregular fibre orientation) or MRI diagnosed mid-portion Achilles tendinopathy with symptoms present =8 weeks but <12 months at screening. - The Achilles tendinopathy must have been refractory to at least 6 weeks of conservative treatment (physiotherapy, NSAIDS, RICE), but participants do not need to be in physiotherapy at the time of study entry. Exclusion Criteria: - Medical condition that would affect safety of peritendon injection (e.g., peripheral vascular disease, use of anticoagulant medication) - History of recurrent, acute, symptomatic infections, including outbreaks of oral or genital herpes (> 2 symptomatic infections or >2 courses of anti-infective treatments required in the last 6 months; active systemic infection during last 2 weeks; known active infections (e.g. chronic or active Hepatis B or C, HIV) - simple cold excluded - History or evidence of clinically significant cardiac or cardiovascular disease - History of deep vein thrombosis, pulmonary embolism or evidence of primary or secondary hypercoagulable states - History of surgical intervention for the treatment of tendinopathy, history of ankle surgery, ankle arthritis, traumatic, inflammation or deformity of ankle - History of full-thickness tear or complete rupture of the Achilles tendon

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
NGI226
NGI226 MP
Placebo
Placebo MP

Locations

Country Name City State
France Novartis Investigative Site Caluire et Cuire
France Novartis Investigative Site Nantes Cedex 1
Germany Novartis Investigative Site Berlin
Germany Novartis Investigative Site Hamburg
United Kingdom Novartis Investigative Site Glasgow
United States Advanced Research LLC Deerfield Beach Florida
United States Houston Methodist Hospital Houston Texas
United States Tucson Orthopedic Institute Tucson Arizona

Sponsors (1)

Lead Sponsor Collaborator
Novartis Pharmaceuticals

Countries where clinical trial is conducted

United States,  France,  Germany,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of participants with AEs and SAEs AEs and SAEs including ECG parameters, Lab Chemistry and Hematology parameters, urinalysis, local tolerability Up to Day 169 (End of Study)
Secondary Changes in tendon stiffness from baseline at week 12 assessed by ultrasound (US)-based shear wave elastography (SWE) To assess the effects of a single peritendon injection of NGI226 MP versus placebo on restoration of biomechanical integrity of Achilles tendon Baseline, Week 12
See also
  Status Clinical Trial Phase
Recruiting NCT04221711 - Safety and Efficacy of Repetitive Peripheral Magnetic Stimulation in Patients With Achilles Tendinopathy N/A
Completed NCT06057779 - The Effect of Loading Speed and Intensity During Exercise on the Immediate Structural Changes in the Achilles Tendon N/A
Active, not recruiting NCT00835939 - Treatment for Achilles Tendinopathy Phase 2/Phase 3
Completed NCT04059146 - Tendinopathy Education on the Achilles N/A
Active, not recruiting NCT06030908 - Outcome After Surgical Reconstruction of the Achilles Tendon Insertion.
Recruiting NCT04423900 - Smart Phone-Based Application for Evaluation and Rehabilitation of HindFoot Pain N/A
Completed NCT04632979 - Backward Running on a Negative Slope as a Treatment for Achilles Tendinopathy in Runners N/A
Terminated NCT03264326 - Efficacy of BFR Training Combined With Eccentric Exercise as Assessed by SWE in Subjects With Chronic AT N/A
Completed NCT04941469 - Effectiveness of Specifically Optimized Off-the-counter Foot Orthosis for the Subtle Cavus Foot N/A
Completed NCT04376294 - Using of Extracorporeal Shockwave Therapy in Treatment Of Achilles Tendinopathy N/A
Recruiting NCT06056440 - Efficacy of a Physical Rehabilitation Program Using Virtual Reality in Patients With Chronic Tendinopathy (Virtendon-Rehab) N/A
Recruiting NCT06172218 - AM for Refractory Achilles Tendinopathy N/A
Recruiting NCT05105269 - Managing Achilles Pain II
Completed NCT06297317 - Longitudinal Changes in Achilles Tendon and Medial Gastrocnemius Muscle Architecture During a 156-km Ultradistance Trail Running Event
Recruiting NCT06100822 - Managing Chronic Tendon Pain by Metformin Phase 1
Completed NCT03067545 - Do Simple Running Technique Changes Reduce Pain and Change Injury Causing Mechanics N/A
Recruiting NCT01583504 - High Volume Saline Injections for Achilles Tendinopathy N/A
Completed NCT04816188 - Heel Pain in Adolescents: A Pilot Study on the Effectiveness of Exercise Therapy and Activity Modification N/A
Completed NCT05125198 - Translation, Cultural Adaptation and Validation of Urdu Version of VISA-A Questionnaire
Recruiting NCT05464498 - Evaluation of Collagen-based Medical Device Treatment Combined With Physiotherapy in Subjects With Achilles Tendinopathy. N/A